Stool Secretory Immunoglobulin A (SIgA) Market: Introduction
According to the report, the global stool secretory immunoglobulin A (SIgA) market was valued at ~US$ 27 Mn in 2019. It is projected to expand at a CAGR of ~3% from 2020 to 2030. Immunological activity in the gastrointestinal tract can be assessed using secretory immunoglobulin A (sIgA). Secretory IgA is the predominant antibody or immune protein; the body manufactures and releases in external secretions such as saliva, tears, and milk. It is also transported through the epithelial cells that line the intestines out into the lumen. Secretory IgA represents the first line of defense of the GI mucosa and is central to the normal function of the GI tract as an immune barrier.
Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B...
North America dominated the global stool secretory immunoglobulin A (SIgA) market in 2019. The trend is anticipated to continue during the forecast period. Rise in research & development activity in the healthcare industry increases the demand for stool secretory immunoglobulin A (SIgA). This is expected to drive the market in the region.
Rise in Adoption of Preventative Care for Healthy Lifestyle to Drive Global Market
Fecal secretory IgA (sIgA) is secreted by mucosal tissue and represents the first line of defense of the GI mucosa, and is central to the normal function of the GI tract as an immune barrier. Elevated levels of fecal secretory IgA have been associated with an upregulated immune response. Hence, physician prefer to evaluate the SIgA level in stool before the treatment method they adopt for various infections in the body, and this drives the market for stool secretory immunoglobulin A (SIgA).
Request COVID Analysis on Stool Secretory Immunoglobulin A Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=c...
Testing to Dominate Global Market
In terms of use, the global stool secretory immunoglobulin A (SIgA) market has been classified into testing and research. Stool test to check the level of SigA in the body is highly sensitive; therefore, it is often produced defense capability of the body to fight against an infection, and also helps to identify the cause of the disease. Moreover, sIgA is the first line of defense against bacteria, food residues, yeast, parasites, viruses, and imbalances, which may provide the link between gut imbalances and systemic illness. Therefore, doctors prefer to carry out the test to check the immunity of the body. This drives the demand for stool secretory immunoglobulin A (SIgA) in testing purposes. The infection testing segment held a major share of the global market in 2019, owing to high prevalence of infectious diseases such as recurrent ear infection and bronchitis in countries such as the U.S.
Labs and Diagnostic Centers to be Key End User
In terms of end user, the global stool secretory immunoglobulin A (SIgA) market has been divided into hospitals, labs and diagnostics centers, and others. A large number of stool secretory immunoglobulin A tests are performed by standalone and hospital-based diagnostic laboratories in the U.S. Furthermore, the presence of major standalone laboratories, such as Laboratory Corporation of America Holdings (LabCorp) testing a higher volume of patient population in the U.S. and Germany. The higher rate of adoption of new tests and instruments by diagnostic laboratories for secretory immunoglobulin A diagnosis are key factors likely to drive the demand for stool secretory immunoglobulin A in the labs and diagnostic centers segment.
Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=E...
North America to Dominate Stool Secretory Immunoglobulin A (SIgA) Market
In terms of region, the global stool secretory immunoglobulin A (SIgA) market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominated the global stool secretory immunoglobulin A (SIgA) market in 2019, followed by Europe. North America accounted for a major share of the global stool secretory immunoglobulin A (SIgA) market in 2019, primarily due to significant ongoing research & development activities in clinical R&D to develop new diagnostic tests and expansion of laboratory test portfolio in the region.
Competition Landscape of Stool Secretory Immunoglobulin A (SIgA) Market
The global stool secretory immunoglobulin A (SIgA) market is fragmented in terms of number of players. Key players in the global stool secretory immunoglobulin A (SIgA) market include BioVendor Group, Sigma Diagnostics Inc., American Laboratory Products Company, Calbiotech, Inc., Eagle Biosciences, R-Biopharm AG, and Tecan Trading AG.
Global Stool Secretory Immunoglobulin A (SIgA) Market: Segmentation
• Stool Secretory Immunoglobulin A (SIgA) Market, by Use
• Testing
o Allergic Disease
o Infection
o GI Inflammation
o Autoimmune Disease
o Others
• Research
• Stool Secretory Immunoglobulin A (SIgA) Market, by End User
• Hospitals
• Labs and Diagnostic Centers
• Others
About Us
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of analysts, researchers, and consultants, uses proprietary data sources and various tools and techniques to gather and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.
Contact
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/